<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Life (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Life (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">2582</journal-id><journal-id journal-id-type="pmc-domain">life</journal-id><journal-id journal-id-type="publisher-id">life</journal-id><journal-title-group><journal-title>Life</journal-title></journal-title-group><issn pub-type="epub">2075-1729</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11204503</article-id><article-id pub-id-type="pmcid-ver">PMC11204503.1</article-id><article-id pub-id-type="pmcaid">11204503</article-id><article-id pub-id-type="pmcaiid">11204503</article-id><article-id pub-id-type="pmid">38929729</article-id><article-id pub-id-type="doi">10.3390/life14060746</article-id><article-id pub-id-type="publisher-id">life-14-00746</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity Score-Matched Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="CY">Cheng-Ya</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="af1-life-14-00746" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liang</surname><given-names initials="YC">Yung-Chun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="af2-life-14-00746" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hsu</surname><given-names initials="WH">Wan-Hsuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-life-14-00746" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tsai</surname><given-names initials="YW">Ya-Wen</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af3-life-14-00746" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3120-8002</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="TH">Ting-Hui</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af4-life-14-00746" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="PY">Po-Yu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-life-14-00746" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chuang</surname><given-names initials="MH">Min-Hsiang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af5-life-14-00746" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4507-8085</contrib-id><name name-style="western"><surname>Hung</surname><given-names initials="KC">Kuo-Chuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af6-life-14-00746" ref-type="aff">6</xref><xref rid="af7-life-14-00746" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="MC">Mei-Chuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af8-life-14-00746" ref-type="aff">8</xref><xref rid="af9-life-14-00746" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="T">Tsung</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af8-life-14-00746" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6334-2388</contrib-id><name name-style="western"><surname>Lai</surname><given-names initials="CC">Chih-Cheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af7-life-14-00746" ref-type="aff">7</xref><xref rid="af10-life-14-00746" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weng</surname><given-names initials="TC">Tzu-Chieh</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af11-life-14-00746" ref-type="aff">11</xref><xref rid="c1-life-14-00746" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3290-1909</contrib-id><name name-style="western"><surname>Wu</surname><given-names initials="JY">Jheng-Yan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af8-life-14-00746" ref-type="aff">8</xref><xref rid="af12-life-14-00746" ref-type="aff">12</xref><xref rid="c1-life-14-00746" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Caputi</surname><given-names initials="A">Antonio</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Walory</surname><given-names initials="J">Jaros&#322;aw</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-life-14-00746"><label>1</label>Division of Cardiovascular Surgery, Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan; <email>lee19920311@hotmail.com.tw</email></aff><aff id="af2-life-14-00746"><label>2</label>Department of Internal Medicine, Chi Mei Medical Center, Tainan 710, Taiwan; <email>paul2760952@gmail.com</email> (Y.-C.L.); <email>nicolar930@gmail.com</email> (W.-H.H.); <email>b0807246@gmail.com</email> (P.-Y.H.)</aff><aff id="af3-life-14-00746"><label>3</label>Division of Preventive Medicine, Chi Mei Medical Center, Tainan 710, Taiwan; <email>rositatsai@gmail.com</email></aff><aff id="af4-life-14-00746"><label>4</label>Department of Psychiatry, Chi Mei Medical Center, Tainan 710, Taiwan; <email>liu.tingkle@gmail.com</email></aff><aff id="af5-life-14-00746"><label>5</label>Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan 710, Taiwan; <email>60028a@gmail.com</email></aff><aff id="af6-life-14-00746"><label>6</label>Department of Anesthesiology, Chi Mei Medical Center, Tainan 710, Taiwan; <email>ed102605@gmail.com</email></aff><aff id="af7-life-14-00746"><label>7</label>School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung City 804, Taiwan; <email>dtmed141@gmail.com</email></aff><aff id="af8-life-14-00746"><label>8</label>Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; <email>pharmacistmeichuanlee@gmail.com</email> (M.-C.L.); <email>tsung.yu.ncku@gmail.com</email> (T.Y.)</aff><aff id="af9-life-14-00746"><label>9</label>Department of Pharmacy, Chi Mei Medical Center, Tainan 710, Taiwan</aff><aff id="af10-life-14-00746"><label>10</label>Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan 710, Taiwan</aff><aff id="af11-life-14-00746"><label>11</label>Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan 710, Taiwan</aff><aff id="af12-life-14-00746"><label>12</label>Department of Nutrition, Chi Mei Medical Center, Tainan 710, Taiwan</aff><author-notes><corresp id="c1-life-14-00746"><label>*</label>Correspondence: <email>wengtzuchieh@gmail.com</email> (T.-C.W.); <email>andy10271@gmail.com</email> (J.-Y.W.)</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2024</year></pub-date><volume>14</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">465512</issue-id><elocation-id>746</elocation-id><history><date date-type="received"><day>19</day><month>5</month><year>2024</year></date><date date-type="rev-recd"><day>08</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>27</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-28 09:25:31.717"><day>28</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="life-14-00746.pdf"/><abstract><p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like malnutrition due to increased metabolic demands and reduced intake during illness. Malnutrition, a significant risk factor, is linked to worse outcomes in patients with COVID-19, such as increased mortality and extended hospital stays. This retrospective cohort study investigated the relationship between malnutrition and clinical outcomes within 90&#8211;180 days using data obtained from the TriNetX database. Patients aged &gt;18 years diagnosed with COVID-19 between 1 January 2022, and 31 March 2024 were enrolled in the study. The propensity score-matching (PSM) method was used to match patients with malnutrition (malnutrition group) and those without malnutrition (control group). The primary composite outcome was the cumulative hazard ratio (HR) for post-COVID-19 condition, all-cause hospitalization, and all-cause mortality between 90 days and 180 days after COVID-19 diagnosis. The secondary outcomes were the individual components of the primary outcomes. Two cohorts, each consisting of 15,004 patients with balanced baseline characteristics, were identified using PSM. During the 90&#8211;180-day follow-up period, the malnutrition group exhibited a higher incidence of all-cause hospitalization, mortality, or post-COVID-19 condition (HR = 2.315, 95% confidence interval: 2.170&#8211;2.471, <italic toggle="yes">p</italic> &lt; 0.0001). Compared with patients with COVID-19 without malnutrition, those with malnutrition may be associated with a higher risk of adverse clinical outcomes.</p></abstract><kwd-group><kwd>malnutrition</kwd><kwd>nutrition deficiency</kwd><kwd>undernutrition</kwd><kwd>COVID-19</kwd><kwd>mortality</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-life-14-00746"><title>1. Introduction</title><p>Coronavirus disease (COVID-19), an acute respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has triggered a global pandemic and public health outbreak [<xref rid="B1-life-14-00746" ref-type="bibr">1</xref>]. As of 5 May 2024, over 700 million cases and 7 million deaths have been reported worldwide [<xref rid="B2-life-14-00746" ref-type="bibr">2</xref>]. The spectrum of symptoms in infected individuals varies widely; some patients remain asymptomatic, while others develop mild symptoms such as cough, chills, fever, fatigue, and dyspnea [<xref rid="B3-life-14-00746" ref-type="bibr">3</xref>,<xref rid="B4-life-14-00746" ref-type="bibr">4</xref>]. More severe manifestations include sepsis, acute respiratory distress syndrome, heart failure, septic shock, and multi-organ dysfunction due to the acute inflammatory response [<xref rid="B5-life-14-00746" ref-type="bibr">5</xref>,<xref rid="B6-life-14-00746" ref-type="bibr">6</xref>]. Beyond these immediate effects, approximately 10% of individuals experience long-term consequences known as the post-acute sequelae of SARS-CoV-2 infection (PASC) or &#8220;long COVID.&#8221; PASC can involve a range of persistent symptoms, including chronic fatigue, respiratory difficulties, cognitive impairment, and cardiovascular issues, extending for months beyond the initial recovery period [<xref rid="B7-life-14-00746" ref-type="bibr">7</xref>,<xref rid="B8-life-14-00746" ref-type="bibr">8</xref>,<xref rid="B9-life-14-00746" ref-type="bibr">9</xref>].</p><p>Building on an understanding of the impact of COVID-19, the factors that can exacerbate the severity of the disease must be investigated. Malnutrition, which can manifest in acute, subacute, or chronic form, is one such factor. It is characterized by progressive weight loss, insufficient energy intake, muscle and fat loss, fluid accumulation, and reduced grip strength [<xref rid="B10-life-14-00746" ref-type="bibr">10</xref>,<xref rid="B11-life-14-00746" ref-type="bibr">11</xref>]. It is a significant independent risk factor for increased morbidity and mortality across various diseases, as it leads to heightened susceptibility to infections or superinfections [<xref rid="B12-life-14-00746" ref-type="bibr">12</xref>].</p><p>Malnutrition may influence the severity of COVID-19 through several mechanisms, including impairment of the immune response, increased inflammation, and delayed recovery. Deficiencies in key nutrients, such as vitamins A, C, and D, zinc, and protein&#8211;energy malnutrition can reduce lymphocyte proliferation, impair immune function and antibody production, and weaken the mucosal barriers that are crucial for preventing pathogen entry. These deficiencies can compromise pulmonary function, which can weaken the respiratory muscles and reduce the pulmonary immune defenses, thereby facilitating more severe respiratory symptoms and extensive viral damage [<xref rid="B10-life-14-00746" ref-type="bibr">10</xref>,<xref rid="B11-life-14-00746" ref-type="bibr">11</xref>,<xref rid="B12-life-14-00746" ref-type="bibr">12</xref>].</p><p>Previous meta-analyses have indicated that nearly 49% of patients with COVID-19 experience malnutrition [<xref rid="B13-life-14-00746" ref-type="bibr">13</xref>]. Observational studies have suggested that malnutrition in these patients correlates with poorer outcomes, including increased rates of mechanical ventilation, mortality, and prolonged hospital stay [<xref rid="B14-life-14-00746" ref-type="bibr">14</xref>,<xref rid="B15-life-14-00746" ref-type="bibr">15</xref>,<xref rid="B16-life-14-00746" ref-type="bibr">16</xref>,<xref rid="B17-life-14-00746" ref-type="bibr">17</xref>,<xref rid="B18-life-14-00746" ref-type="bibr">18</xref>,<xref rid="B19-life-14-00746" ref-type="bibr">19</xref>].</p><p>However, much of the existing evidence is derived from retrospective studies conducted at a single center. Therefore, more comprehensive studies with larger sample sizes are needed. This study aimed to explore the association between malnutrition and clinical outcomes in patients with SARS-CoV-2 infection over a period of 90&#8211;180 days using an international database.</p></sec><sec id="sec2-life-14-00746"><title>2. Materials and Methods</title><sec id="sec2dot1-life-14-00746"><title>2.1. Data Source</title><p>The data used in this study were collected from the TriNetX Research Network. The TriNetX database shares electronic medical record data (diagnoses, procedures, medications, laboratory values, genomic information, and types of visits) of approximately 140 million individuals at 119 healthcare organizations (HCOs) [<xref rid="B20-life-14-00746" ref-type="bibr">20</xref>]. Numerous observational studies have utilized the TriNetX database, particularly when conducting COVID-19 research [<xref rid="B21-life-14-00746" ref-type="bibr">21</xref>,<xref rid="B22-life-14-00746" ref-type="bibr">22</xref>,<xref rid="B23-life-14-00746" ref-type="bibr">23</xref>,<xref rid="B24-life-14-00746" ref-type="bibr">24</xref>]. The TriNetX platform provides integrated tools for analyzing patient-level data and presents outcomes to researchers as consolidated reports. Considering that the data utilized from TriNetX were anonymized, written informed consent was not required. This study was approved by the Institutional Review Board of the Chi Mei Medical Center (approval no. 11302-E01).</p></sec><sec id="sec2dot2-life-14-00746"><title>2.2. Patient Selection and Exposure</title><p>Patients aged &gt;18 years who had more than two visits to HCOs from 1 January 2022 to 31 March 2024 and were diagnosed with COVID-19 (confirmed by a positive polymerase chain reaction test [laboratory test code with TNX: LAB:9088] or an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code U07.1) [<xref rid="B25-life-14-00746" ref-type="bibr">25</xref>,<xref rid="B26-life-14-00746" ref-type="bibr">26</xref>,<xref rid="B27-life-14-00746" ref-type="bibr">27</xref>] were included in the study. To ensure consistency in terms of disease severity, patients who died within 90 days or were hospitalized within 7 days after contracting COVID-19 were excluded. Patients were further divided into the malnutrition and control groups based on whether they exhibited signs of malnutrition (ICD-10 cm codes: E40&#8211;E46) within 90 days before the index date. Our initial cohort from 1 January 2022 to 31 March 2024, consisted of 3,038,057 patients with COVID-19, including 23,364 with malnutrition and 3,014,693 without malnutrition (<xref rid="life-14-00746-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2dot3-life-14-00746"><title>2.3. Covariates</title><p>To balance the distribution between groups at baseline, we selected covariates for matching based on CDC [<xref rid="B28-life-14-00746" ref-type="bibr">28</xref>]. The baseline variables used to match the two study groups included (a) demographics such as age, sex, and race; (b) potential health risks linked to socioeconomic factors, including housing and financial conditions, educational attainment and literacy levels, employment status, and occupational exposure to hazards; and (c) comorbid conditions such as alcohol-related disorders, nicotine dependence, hypertension, hyperlipidemia, diabetes mellitus, neoplasms, chronic diseases of the lower respiratory tract, liver diseases, chronic kidney disease, end-stage renal disease, cerebrovascular disease, heart failure, and atrial fibrillation.</p></sec><sec id="sec2dot4-life-14-00746"><title>2.4. Outcomes</title><p>The primary outcome of this study was a composite of all-cause hospitalization, all-cause mortality, or post-COVID-19 condition. The secondary outcomes were the individual components of the primary outcome, including all-cause hospitalization, all-cause mortality, and post-COVID-19 condition. The follow-up period was 90&#8211;180 days after the index date.</p></sec><sec id="sec2dot5-life-14-00746"><title>2.5. Statistical Analysis</title><p>Statistical analyses were performed using the integrated functions of the TriNetX platform. The baseline characteristics of the malnutrition and control groups were expressed as the means, standard deviations, counts, and percentages. To correct imbalances in baseline covariates, a 1:1 PSM was employed. The PSM technique utilized a nearest-neighbor matching algorithm with a caliper width set at 0.1 of pooled standard deviations. Variables with a standardized difference of less than 0.1 between groups were considered adequately matched. Following PSM, the cumulative incidence of each outcome was estimated using Cox regression models and the results were expressed as hazard ratios (HRs) with 95% confidence intervals (CIs). Additionally, Kaplan&#8211;Meier curves were generated to assess the survival distributions between the groups, with significance evaluated using the log-rank test. A <italic toggle="yes">p</italic> value of &lt;0.05 was considered significant.</p></sec><sec id="sec2dot6-life-14-00746"><title>2.6. Subgroup Analysis</title><p>Subgroup analyses were performed using a stratified approach to explore variations in outcomes based on sex, age, race, vaccination status, and the antiviral agent used.</p></sec></sec><sec sec-type="results" id="sec3-life-14-00746"><title>3. Results</title><sec id="sec3dot1-life-14-00746"><title>3.1. Demographic Characteristics</title><p>The baseline characteristics of the two groups are presented in <xref rid="life-14-00746-t001" ref-type="table">Table 1</xref>. Prior to PSM, notable differences were noted in the demographic and health profiles of the two groups. Specifically, individuals in the malnutrition group were generally older than those in the control group (mean age: 66.0 &#177; 17.5 vs. 50.6 &#177; 19.2). The malnutrition group also had a higher proportion of women (58.7% vs. 46.4%). In terms of comorbidities, the malnutrition group exhibited a higher prevalence of alcohol-related disorders (8.9% vs. 2.6%), nicotine dependence (17.7% vs. 7.9%), hypertension (52.4% vs. 30%), hyperlipidemia (41.4% vs. 28.4%), diabetes mellitus (29.4% vs. 14.4%), neoplasms (34.3% vs. 20.5%), chronic lower respiratory diseases (25.5% vs. 15.3%), liver diseases (15.9% vs. 6.3%), chronic kidney disease (22.4% vs. 6.6%), end-stage renal disease (4.8% vs. 1.1%), cerebrovascular diseases (20.1% vs. 4.9%), atrial fibrillation and flutter (16.5% vs. 4.9%), and ischemic heart diseases (27.3% vs. 9.5%). Following PSM, both groups comprised 15,004 patients, each with well-balanced demographic characteristics, as summarized in <xref rid="life-14-00746-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec3dot2-life-14-00746"><title>3.2. Primary Outcomes</title><p>During the 90&#8211;180-day follow-up period, the all-cause hospitalization, mortality, or long COVID-19 rate was higher in the malnutrition group (17.9%) than in the control group (9.2%), with an HR of 2.315 (95% CI: 2.170&#8211;2.471, <italic toggle="yes">p</italic> &lt; 0.001; <xref rid="life-14-00746-f002" ref-type="fig">Figure 2</xref>, <xref rid="life-14-00746-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3dot3-life-14-00746"><title>3.3. Secondary Outcomes</title><p>For the individual component outcomes during the 90&#8211;180-day follow-up period, the malnutrition group showed a higher risk of all-cause hospitalization (HR = 2.151, 95% CI: 2.008&#8211;2.304), all-cause mortality (HR = 4.459, 95% CI: 3.699&#8211;5.376), and post-COVID-19 condition (HR = 2.707, 95% CI: 1.913&#8211;3.832) than the control group (<xref rid="life-14-00746-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3dot4-life-14-00746"><title>3.4. Subgroup Analysis</title><p>The risk of the primary outcome was examined based on age, sex, race, vaccination status, and the antiviral agent used (<xref rid="life-14-00746-t003" ref-type="table">Table 3</xref>). Subgroup analyses showed consistent results for each subgroup. In terms of the other secondary outcomes, similar trends were observed in the subgroup analyses (<xref rid="life-14-00746-t004" ref-type="table">Table 4</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-life-14-00746"><title>4. Discussion</title><p>This study used a large sample size to investigate the association between malnutrition and clinical outcomes in patients with COVID-19 over a 90&#8211;180-day follow-up period. Our findings highlight that patients with COVID-19 experiencing malnutrition have a significantly higher risk of severe outcomes, including all-cause hospitalization, all-cause mortality, and post-COVID-19 condition. Notably, the effect size of all-cause mortality in the malnutrition group was fourfold higher than that in the control group, indicating a substantial impact of nutritional status on COVID-19 severity.</p><p>The underlying mechanisms by which malnutrition exacerbates COVID-19 severity involve both direct and indirect effects on patient health. Malnutrition weakens immune defense mechanisms, as evidenced by a reduced lymphocyte count and impaired phagocytic function, which are critical for combating viral infections [<xref rid="B29-life-14-00746" ref-type="bibr">29</xref>,<xref rid="B30-life-14-00746" ref-type="bibr">30</xref>]. Deficiencies in essential proteins, vitamins, and minerals further weaken physical barriers and cellular immunity. This predisposition not only increases susceptibility to severe infections but also increases the risk of prolonged illness and complications [<xref rid="B31-life-14-00746" ref-type="bibr">31</xref>,<xref rid="B32-life-14-00746" ref-type="bibr">32</xref>,<xref rid="B33-life-14-00746" ref-type="bibr">33</xref>,<xref rid="B34-life-14-00746" ref-type="bibr">34</xref>].</p><p>Furthermore, malnutrition exacerbates the inflammatory cascade associated with COVID-19. It induces an imbalanced cytokine profile, promoting inflammatory pathways that can lead to the occurrence of cytokine storm syndrome, a known predictor of severe outcomes in COVID-19. Uncontrolled inflammation can result in tissue damage, multi-organ failure, and heightened mortality risk [<xref rid="B32-life-14-00746" ref-type="bibr">32</xref>,<xref rid="B35-life-14-00746" ref-type="bibr">35</xref>,<xref rid="B36-life-14-00746" ref-type="bibr">36</xref>,<xref rid="B37-life-14-00746" ref-type="bibr">37</xref>,<xref rid="B38-life-14-00746" ref-type="bibr">38</xref>,<xref rid="B39-life-14-00746" ref-type="bibr">39</xref>].</p><p>Consistent with previous studies, malnutrition amplifies the severity of infectious diseases, including COVID-19 [<xref rid="B3-life-14-00746" ref-type="bibr">3</xref>,<xref rid="B12-life-14-00746" ref-type="bibr">12</xref>,<xref rid="B40-life-14-00746" ref-type="bibr">40</xref>,<xref rid="B41-life-14-00746" ref-type="bibr">41</xref>,<xref rid="B42-life-14-00746" ref-type="bibr">42</xref>,<xref rid="B43-life-14-00746" ref-type="bibr">43</xref>,<xref rid="B44-life-14-00746" ref-type="bibr">44</xref>]. A meta-analysis of 12 studies demonstrated a similar trend, showing that malnourished patients had significantly higher odds of in-hospital mortality (odds ratio = 3.43, 95% CI: 2.55&#8211;4.60) during a 90-day follow-up [<xref rid="B45-life-14-00746" ref-type="bibr">45</xref>]. Our study builds on these findings by including non-hospitalized patients and extending the follow-up duration, thus providing a more comprehensive view of the impact of malnutrition on COVID-19 outcomes in various settings. Additionally, our study addressed some of the limitations observed in previous studies, such as small sample sizes and short follow-up periods, by utilizing a larger and more diverse cohort with a longer observation period. This approach enhances the generalizability and applicability of our findings, suggesting robust associations across various healthcare settings and populations.</p><p>The strong association between malnutrition and adverse COVID-19 outcomes underscores the necessity of early nutritional screening and intervention in patients with COVID-19. The implementation of nutritional support strategies can potentially reduce disease severity and improve clinical outcomes. Physicians and dietitians should consider integrated care pathways that incorporate nutritional assessments and tailored interventions as part of standard care for patients with COVID-19.</p><p>Although our findings are significant, they highlight the need for further research to explore the causal relationships and effectiveness of specific nutritional interventions in improving COVID-19 prognosis. Prospective and randomized controlled trials are essential to determine the specific nutrients and dietary interventions that are most effective in mitigating the impact of malnutrition on COVID-19 severity.</p><p>This study has several strengths. First, although the existing research often relies on data from a single hospital with limited sample sizes and generalizability, our study draws from a vast and diverse population. This diversity enhances the relevance and generalizability of our findings to broader real-world settings. Second, we employed PSM to ensure comparability between the groups, effectively controlling for potential confounding factors related to the variables of interest and observed outcomes. Finally, the consistency observed across various subgroup analyses adds further credibility to our findings.</p><p>This study has some limitations. First, potential information bias and coding errors in the electronic health records database may have occurred; however, these errors were likely consistent between the groups, which minimizes their impact on our findings [<xref rid="B46-life-14-00746" ref-type="bibr">46</xref>]. Second, relying on ICD-10 cm codes to determine the history of malnutrition may underestimate its true prevalence. Third, although our data suggest significant associations, they do not establish causality. Fourth, due to database limitations, we could not determine the countries from which these patients originated. Finally, to control for disease severity and reduce heterogeneity, we excluded patients who were initially hospitalized and deceased within 90 days from the index date, limiting the generalizability of our findings.</p></sec><sec sec-type="conclusions" id="sec5-life-14-00746"><title>5. Conclusions</title><p>This study demonstrated that malnutrition is associated with a significantly higher risk of all-cause hospitalization, mortality, or post-COVID-19 condition compared with the control group. Therefore, malnutrition is a potential risk factor for poor clinical outcomes in patients with COVID-19. These findings highlight the critical role of malnutrition in exacerbating the severity of COVID-19. The robustness of the data, enhanced by the large sample size and diverse patient population, provides compelling evidence supporting the integration of nutritional evaluations and interventions in the management of COVID-19.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, C.-Y.L., T.-C.W. and J.-Y.W.; methodology, T.-H.L.; software, M.-H.C.; validation, W.-H.H. and Y.-W.T.; writing&#8212;original draft preparation, Y.-C.L.; writing&#8212;review and editing, K.-C.H., M.-C.L., T.Y., C.-C.L., T.-C.W. and J.-Y.W.; visualization, W.-H.H. and P.-Y.H. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was approved by the Institutional Review Board of the Chi Mei Medical Center (approval no. 11302-E01).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was not obtained, since all data were taken anonymously from the database of the hospital.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-life-14-00746"><label>1.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Coronavirus (COVID-19) Dashboard</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://covid19.who.int/" ext-link-type="uri">https://covid19.who.int/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-05-09">(accessed on 9 May 2024)</date-in-citation></element-citation></ref><ref id="B2-life-14-00746"><label>2.</label><element-citation publication-type="webpage"><article-title>World Health Organization</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" ext-link-type="uri">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-05-19">(accessed on 19 May 2024)</date-in-citation></element-citation></ref><ref id="B3-life-14-00746"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barazzoni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Busetto</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cederholm</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chourdakis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cuerda</surname><given-names>C.</given-names></name><name name-style="western"><surname>Delzenne</surname><given-names>N.</given-names></name><name name-style="western"><surname>Genton</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance</article-title><source>Clin. Nutr.</source><year>2022</year><volume>41</volume><fpage>2869</fpage><lpage>2886</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2021.05.006</pub-id><pub-id pub-id-type="pmid">34140163</pub-id><pub-id pub-id-type="pmcid">PMC8110326</pub-id></element-citation></ref><ref id="B4-life-14-00746"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e28430</fpage><pub-id pub-id-type="doi">10.1002/jmv.28430</pub-id><pub-id pub-id-type="pmid">36571273</pub-id><pub-id pub-id-type="pmcid">PMC9880661</pub-id></element-citation></ref><ref id="B5-life-14-00746"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barazzoni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Breda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wickramasinghe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Krznaric</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Nitzan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pirlich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>P.</given-names></name></person-group><article-title>ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection</article-title><source>Clin. Nutr.</source><year>2020</year><volume>39</volume><fpage>1631</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2020.03.022</pub-id><pub-id pub-id-type="pmid">32305181</pub-id><pub-id pub-id-type="pmcid">PMC7138149</pub-id></element-citation></ref><ref id="B6-life-14-00746"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P.I.</given-names></name><name name-style="western"><surname>Jean</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Extra-respiratory manifestations of COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>56</volume><fpage>106024</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.106024</pub-id><pub-id pub-id-type="pmid">32450197</pub-id><pub-id pub-id-type="pmcid">PMC7243791</pub-id></element-citation></ref><ref id="B7-life-14-00746"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>McCorkell</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Topol</surname><given-names>E.J.</given-names></name></person-group><article-title>Long COVID: Major findings, mechanisms and recommendations</article-title><source>Nat. Rev. Microbiol.</source><year>2023</year><volume>21</volume><fpage>133</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/s41579-022-00846-2</pub-id><pub-id pub-id-type="pmid">36639608</pub-id><pub-id pub-id-type="pmcid">PMC9839201</pub-id></element-citation></ref><ref id="B8-life-14-00746"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P.I.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Long COVID: An inevitable sequela of SARS-CoV-2 infection</article-title><source>J. Microbiol. Immunol. Infect.</source><year>2023</year><volume>56</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2022.10.003</pub-id><pub-id pub-id-type="pmid">36283919</pub-id><pub-id pub-id-type="pmcid">PMC9576029</pub-id></element-citation></ref><ref id="B9-life-14-00746"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nalbandian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sehgal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Madhavan</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>McGroder</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Nordvig</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Shalev</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sehrawat</surname><given-names>T.S.</given-names></name><etal/></person-group><article-title>Post-acute COVID-19 syndrome</article-title><source>Nat. Med.</source><year>2021</year><volume>27</volume><fpage>601</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01283-z</pub-id><pub-id pub-id-type="pmid">33753937</pub-id><pub-id pub-id-type="pmcid">PMC8893149</pub-id></element-citation></ref><ref id="B10-life-14-00746"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>Guenter</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Malone</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schofield</surname><given-names>M.</given-names></name></person-group><article-title>Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)</article-title><source>JPEN J. Parenter. Enteral Nutr.</source><year>2012</year><volume>36</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1177/0148607112440285</pub-id><pub-id pub-id-type="pmid">22535923</pub-id></element-citation></ref><ref id="B11-life-14-00746"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Mirtallo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Compher</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dhaliwal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grijalba</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kondrup</surname><given-names>J.</given-names></name><name name-style="western"><surname>Labadarios</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nyulasi</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Adult starvation and disease-related malnutrition: A proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee</article-title><source>JPEN J. Parenter. Enteral Nutr.</source><year>2010</year><volume>34</volume><fpage>156</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1177/0148607110361910</pub-id><pub-id pub-id-type="pmid">20375423</pub-id></element-citation></ref><ref id="B12-life-14-00746"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Veyres</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pivot</surname><given-names>X.</given-names></name><name name-style="western"><surname>Soummer</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Jambou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Filippi</surname><given-names>J.</given-names></name><name name-style="western"><surname>van Obberghen</surname><given-names>E.</given-names></name><name name-style="western"><surname>H&#233;buterne</surname><given-names>X.</given-names></name></person-group><article-title>Malnutrition is an independent factor associated with nosocomial infections</article-title><source>Br. J. Nutr.</source><year>2004</year><volume>92</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1079/bjn20041152</pub-id><pub-id pub-id-type="pmid">15230993</pub-id></element-citation></ref><ref id="B13-life-14-00746"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abate</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Chekole</surname><given-names>Y.A.</given-names></name><name name-style="western"><surname>Estifanos</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Abate</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Kabthymer</surname><given-names>R.H.</given-names></name></person-group><article-title>Prevalence and outcomes of malnutrition among hospitalized COVID-19 patients: A systematic review and meta-analysis</article-title><source>Clin. Nutr. ESPEN</source><year>2021</year><volume>43</volume><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.clnesp.2021.03.002</pub-id><pub-id pub-id-type="pmid">34024511</pub-id><pub-id pub-id-type="pmcid">PMC7968150</pub-id></element-citation></ref><ref id="B14-life-14-00746"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurtz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grant</surname><given-names>K.</given-names></name><name name-style="western"><surname>Marano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arrieta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grant</surname><given-names>K.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Feaster</surname><given-names>W.</given-names></name><name name-style="western"><surname>Steele</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ehwerhemuepha</surname><given-names>L.</given-names></name></person-group><article-title>Long-term effects of malnutrition on severity of COVID-19</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>14974</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-94138-z</pub-id><pub-id pub-id-type="pmid">34294743</pub-id><pub-id pub-id-type="pmcid">PMC8298504</pub-id></element-citation></ref><ref id="B15-life-14-00746"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allard</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ouedraogo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Molleville</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bihan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Giroux-Leprieur</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baudry</surname><given-names>C.</given-names></name><name name-style="western"><surname>Josse</surname><given-names>C.</given-names></name><name name-style="western"><surname>Didier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deutsch</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for Coronavirus Disease 2019</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>3679</elocation-id><pub-id pub-id-type="doi">10.3390/nu12123679</pub-id><pub-id pub-id-type="pmid">33260603</pub-id><pub-id pub-id-type="pmcid">PMC7761464</pub-id></element-citation></ref><ref id="B16-life-14-00746"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Predictive value of the prognostic nutritional index for the severity of coronavirus disease 2019</article-title><source>Nutrition</source><year>2021</year><volume>84</volume><fpage>111123</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2020.111123</pub-id><pub-id pub-id-type="pmid">33476998</pub-id><pub-id pub-id-type="pmcid">PMC7747677</pub-id></element-citation></ref><ref id="B17-life-14-00746"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Ba</surname><given-names>Y.M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.M.</given-names></name><name name-style="western"><surname>Song</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X.B.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Q.F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>You</surname><given-names>S.S.</given-names></name></person-group><article-title>Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study</article-title><source>Clin. Nutr.</source><year>2021</year><volume>40</volume><fpage>2154</fpage><lpage>2161</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2020.09.040</pub-id><pub-id pub-id-type="pmid">33077274</pub-id><pub-id pub-id-type="pmcid">PMC7527833</pub-id></element-citation></ref><ref id="B18-life-14-00746"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name></person-group><article-title>Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China</article-title><source>Eur. J. Clin. Nutr.</source><year>2020</year><volume>74</volume><fpage>871</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1038/s41430-020-0642-3</pub-id><pub-id pub-id-type="pmid">32322046</pub-id><pub-id pub-id-type="pmcid">PMC7175450</pub-id></element-citation></ref><ref id="B19-life-14-00746"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>He</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>D.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Y.</given-names></name></person-group><article-title>The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients</article-title><source>Clin. Nutr.</source><year>2021</year><volume>40</volume><fpage>534</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2020.05.051</pub-id><pub-id pub-id-type="pmid">32527576</pub-id><pub-id pub-id-type="pmcid">PMC7273137</pub-id></element-citation></ref><ref id="B20-life-14-00746"><label>20.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>TriNetX</collab></person-group><article-title>TriNetX Research Network</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://trinetx.com/" ext-link-type="uri">https://trinetx.com/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-05-09">(accessed on 9 May 2024)</date-in-citation></element-citation></ref><ref id="B21-life-14-00746"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>W.B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Yong</surname><given-names>S.B.</given-names></name></person-group><article-title>Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2,442,686 patients</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e29101</fpage><pub-id pub-id-type="doi">10.1002/jmv.29101</pub-id><pub-id pub-id-type="pmid">37698139</pub-id></element-citation></ref><ref id="B22-life-14-00746"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e28750</fpage><pub-id pub-id-type="doi">10.1002/jmv.28750</pub-id><pub-id pub-id-type="pmid">37185834</pub-id></element-citation></ref><ref id="B23-life-14-00746"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors</article-title><source>J. Infect.</source><year>2023</year><volume>86</volume><fpage>e107</fpage><lpage>e110</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2023.02.007</pub-id><pub-id pub-id-type="pmid">36773894</pub-id><pub-id pub-id-type="pmcid">PMC9911974</pub-id></element-citation></ref><ref id="B24-life-14-00746"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e28866</fpage><pub-id pub-id-type="doi">10.1002/jmv.28866</pub-id><pub-id pub-id-type="pmid">37314228</pub-id></element-citation></ref><ref id="B25-life-14-00746"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Shiue</surname><given-names>Y.L.</given-names></name></person-group><article-title>Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e28869</fpage><pub-id pub-id-type="doi">10.1002/jmv.28869</pub-id><pub-id pub-id-type="pmid">37322616</pub-id></element-citation></ref><ref id="B26-life-14-00746"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data</article-title><source>J. Med. Virol.</source><year>2023</year><volume>95</volume><fpage>e28801</fpage><pub-id pub-id-type="doi">10.1002/jmv.28801</pub-id><pub-id pub-id-type="pmid">37218308</pub-id></element-citation></ref><ref id="B27-life-14-00746"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients</article-title><source>J. Infect.</source><year>2023</year><volume>86</volume><fpage>256</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2023.01.014</pub-id><pub-id pub-id-type="pmcid">PMC9840225</pub-id><pub-id pub-id-type="pmid">36649824</pub-id></element-citation></ref><ref id="B28-life-14-00746"><label>28.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>CDC</collab></person-group><article-title>Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-04-06">(accessed on 6 April 2024)</date-in-citation></element-citation></ref><ref id="B29-life-14-00746"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foolchand</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ghazi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chuturgoon</surname><given-names>A.A.</given-names></name></person-group><article-title>Malnutrition and Dietary Habits Alter the Immune System Which May Consequently Influence SARS-CoV-2 Virulence: A Review</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>2654</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23052654</pub-id><pub-id pub-id-type="pmid">35269795</pub-id><pub-id pub-id-type="pmcid">PMC8910702</pub-id></element-citation></ref><ref id="B30-life-14-00746"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadi</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Behjati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karami</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abari</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Sobhani-Nasab</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rourani</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Hazrati</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mirghazanfari</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Hadi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hadi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>An overview on role of nutrition on COVID-19 immunity: Accumulative review from available studies</article-title><source>Clin. Nutr. Open Sci.</source><year>2023</year><volume>47</volume><fpage>6</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.nutos.2022.11.001</pub-id><pub-id pub-id-type="pmid">36540357</pub-id><pub-id pub-id-type="pmcid">PMC9754583</pub-id></element-citation></ref><ref id="B31-life-14-00746"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iddir</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brito</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dingeo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fernandez Del Campo</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Samouda</surname><given-names>H.</given-names></name><name name-style="western"><surname>La Frano</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Bohn</surname><given-names>T.</given-names></name></person-group><article-title>Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1562</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061562</pub-id><pub-id pub-id-type="pmid">32471251</pub-id><pub-id pub-id-type="pmcid">PMC7352291</pub-id></element-citation></ref><ref id="B32-life-14-00746"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>The nutritional roles of zinc for immune system and COVID-19 patients</article-title><source>Front. Nutr.</source><year>2024</year><volume>11</volume><fpage>1385591</fpage><pub-id pub-id-type="doi">10.3389/fnut.2024.1385591</pub-id><pub-id pub-id-type="pmid">38706559</pub-id><pub-id pub-id-type="pmcid">PMC11066294</pub-id></element-citation></ref><ref id="B33-life-14-00746"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamilian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ghalichi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hamedi Kalajahi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Radkhah</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jourabchi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Musazadeh</surname><given-names>V.</given-names></name><name name-style="western"><surname>Amini-Salehi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zarezadeh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ostadrahimi</surname><given-names>A.</given-names></name></person-group><article-title>The role of vitamin D in outcomes of critical care in COVID-19 patients: Evidence from an umbrella meta-analysis of interventional and observational studies</article-title><source>Public Health Nutr.</source><year>2024</year><volume>27</volume><fpage>e127</fpage><pub-id pub-id-type="doi">10.1017/s1368980024000934</pub-id><pub-id pub-id-type="pmid">38654693</pub-id><pub-id pub-id-type="pmcid">PMC11112434</pub-id></element-citation></ref><ref id="B34-life-14-00746"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>SeyedAlinaghi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shahidi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mojdeganlou</surname><given-names>H.</given-names></name><name name-style="western"><surname>Akhtaran</surname><given-names>F.K.</given-names></name><name name-style="western"><surname>Maroufi</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Maroufi</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Mirzapour</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khodaei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pour</surname><given-names>M.M.</given-names></name><etal/></person-group><article-title>The effect of macronutrient and micronutrient supplements on COVID-19: An umbrella review</article-title><source>J. Health Popul. Nutr.</source><year>2024</year><volume>43</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s41043-024-00504-8</pub-id><pub-id pub-id-type="pmid">38287379</pub-id><pub-id pub-id-type="pmcid">PMC10826055</pub-id></element-citation></ref><ref id="B35-life-14-00746"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dellino</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cascardi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vinciguerra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lamanna</surname><given-names>B.</given-names></name><name name-style="western"><surname>Malvasi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scacco</surname><given-names>S.</given-names></name><name name-style="western"><surname>Acquaviva</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>V.</given-names></name><name name-style="western"><surname>Di Vagno</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cormio</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>9136</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23169136</pub-id><pub-id pub-id-type="pmid">36012402</pub-id><pub-id pub-id-type="pmcid">PMC9409275</pub-id></element-citation></ref><ref id="B36-life-14-00746"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grund</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>J.M.</given-names></name></person-group><article-title>Malnutrition and Sarcopenia in COVID-19 Survivors</article-title><source>Clin. Geriatr. Med.</source><year>2022</year><volume>38</volume><fpage>559</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1016/j.cger.2022.04.001</pub-id><pub-id pub-id-type="pmid">35868673</pub-id><pub-id pub-id-type="pmcid">PMC9021037</pub-id></element-citation></ref><ref id="B37-life-14-00746"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiang</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Kalantar-Zadeh</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A.</given-names></name></person-group><article-title>Thymic Dysfunction and Atrophy in COVID-19 Disease Complicated by Inflammation, Malnutrition and Cachexia</article-title><source>Nutr. Health</source><year>2022</year><volume>28</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1177/02601060221083160</pub-id><pub-id pub-id-type="pmid">35234100</pub-id><pub-id pub-id-type="pmcid">PMC8891908</pub-id></element-citation></ref><ref id="B38-life-14-00746"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Garc&#237;a-Almeida</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Mat&#237;a-Mart&#237;n</surname><given-names>P.</given-names></name><name name-style="western"><surname>Palma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sanz-Paris</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zugasti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alfaro</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Fullana</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Continente</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Chicetru</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection</article-title><source>Rev. Endocr. Metab. Disord.</source><year>2022</year><volume>23</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/s11154-022-09714-z</pub-id><pub-id pub-id-type="pmid">35244834</pub-id><pub-id pub-id-type="pmcid">PMC8895363</pub-id></element-citation></ref><ref id="B39-life-14-00746"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>D.</given-names></name><name name-style="western"><surname>De Francesco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Riso</surname><given-names>S.</given-names></name><name name-style="western"><surname>Collo</surname><given-names>A.</given-names></name></person-group><article-title>Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview</article-title><source>Nutrition</source><year>2021</year><volume>81</volume><fpage>111016</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2020.111016</pub-id><pub-id pub-id-type="pmid">33059127</pub-id><pub-id pub-id-type="pmcid">PMC7832575</pub-id></element-citation></ref><ref id="B40-life-14-00746"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;n-Mart&#237;nez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vi&#241;as</surname><given-names>P.</given-names></name><name name-style="western"><surname>Carrillo</surname><given-names>I.</given-names></name><name name-style="western"><surname>Martos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Clav&#233;</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ortega</surname><given-names>O.</given-names></name></person-group><article-title>The Impact of Frailty, Oropharyngeal Dysphagia and Malnutrition on Mortality in Older Patients Hospitalized for COVID-19</article-title><source>Aging Dis.</source><year>2024</year><volume>15</volume><fpage>927</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.14336/ad.2023.0425-2</pub-id><pub-id pub-id-type="pmid">37548930</pub-id><pub-id pub-id-type="pmcid">PMC10917529</pub-id></element-citation></ref><ref id="B41-life-14-00746"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jima</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Atomsa</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Allard</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Nigatu</surname><given-names>Y.D.</given-names></name></person-group><article-title>The effect of malnutrition on adult Covid-19 patient&#8217;s ICU admission and mortality in Covid-19 isolation and treatment centers in Ethiopia: A prospective cohort study</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0298215</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0298215</pub-id><pub-id pub-id-type="pmid">38507372</pub-id><pub-id pub-id-type="pmcid">PMC10954135</pub-id></element-citation></ref><ref id="B42-life-14-00746"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barazzoni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Breda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cuerda</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>S.</given-names></name><name name-style="western"><surname>Deutz</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Wickramasinghe</surname><given-names>K.</given-names></name></person-group><article-title>COVID-19: Lessons on malnutrition, nutritional care and public health from the ESPEN-WHO Europe call for papers</article-title><source>Clin. Nutr.</source><year>2022</year><volume>41</volume><fpage>2858</fpage><lpage>2868</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2022.07.033</pub-id><pub-id pub-id-type="pmid">36075815</pub-id><pub-id pub-id-type="pmcid">PMC9365508</pub-id></element-citation></ref><ref id="B43-life-14-00746"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name></person-group><article-title>Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><year>2023</year><volume>62</volume><fpage>106984</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2023.106984</pub-id><pub-id pub-id-type="pmid">37769748</pub-id></element-citation></ref><ref id="B44-life-14-00746"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Hung</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>S.C.</given-names></name><etal/></person-group><article-title>The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19</article-title><source>Expert. Rev. Anti Infect. Ther.</source><year>2024</year><volume>22</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1080/14787210.2024.2303017</pub-id><pub-id pub-id-type="pmid">38178687</pub-id></element-citation></ref><ref id="B45-life-14-00746"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kaufman-Shriqui</surname><given-names>V.</given-names></name></person-group><article-title>Systematic Review and Meta-Analysis: Malnutrition and In-Hospital Death in Adults Hospitalized with COVID-19</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>1298</elocation-id><pub-id pub-id-type="doi">10.3390/nu15051298</pub-id><pub-id pub-id-type="pmid">36904295</pub-id><pub-id pub-id-type="pmcid">PMC10005527</pub-id></element-citation></ref><ref id="B46-life-14-00746"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Copeland</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Checkoway</surname><given-names>H.</given-names></name><name name-style="western"><surname>McMichael</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Holbrook</surname><given-names>R.H.</given-names></name></person-group><article-title>Bias due to misclassification in the estimation of relative risk</article-title><source>Am. J. Epidemiol.</source><year>1977</year><volume>105</volume><fpage>488</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a112408</pub-id><pub-id pub-id-type="pmid">871121</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="life-14-00746-f001" orientation="portrait"><label>Figure 1</label><caption><p>Flowchart of the participant selection process. HCOs: healthcare organizations; y/o: years old; PCR: polymerase chain reaction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="life-14-00746-g001.jpg"/></fig><fig position="float" id="life-14-00746-f002" orientation="portrait"><label>Figure 2</label><caption><p>Kaplan&#8211;Meier event-free curves for the primary outcome: a composite of all-cause hospitalization, all-cause mortality, or post-COVID-19 condition.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="life-14-00746-g002.jpg"/></fig><table-wrap position="float" id="life-14-00746-t001" orientation="portrait"><object-id pub-id-type="pii">life-14-00746-t001_Table 1</object-id><label>Table 1</label><caption><p>Baseline characteristics of the study participants before and after the implementation of propensity-score matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Variables</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Before Matching</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">After Matching</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malnutrition Group<break/>(n = 15,004)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control Group<break/>(n = 2,662,662)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Std<break/>Diff</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malnutrition Group<break/>(n = 15,004)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control Group<break/>(n = 15,004)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Std<break/>Diff</th></tr></thead><tbody><tr><td colspan="7" align="left" valign="middle" rowspan="1">Age at index, years</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Mean &#177; SD</td><td align="center" valign="middle" rowspan="1" colspan="1">66.0 &#177; 17.5</td><td align="center" valign="middle" rowspan="1" colspan="1">50.6 &#177; 19.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84</td><td align="center" valign="middle" rowspan="1" colspan="1">66.0 &#177; 17.5</td><td align="center" valign="middle" rowspan="1" colspan="1">66.8 &#177; 17.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">Gender, n (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">6960 (46.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1,562,584 (58.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">6960 (46.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">7027 (46.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">7208 (48)</td><td align="center" valign="middle" rowspan="1" colspan="1">992,649 (37.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">7208 (48)</td><td align="center" valign="middle" rowspan="1" colspan="1">7125 (47.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">Race, n (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;White</td><td align="center" valign="middle" rowspan="1" colspan="1">8687 (57.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1,557,689 (58.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">8687 (57.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">8695 (58)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;American Indian or Alaska Native</td><td align="center" valign="middle" rowspan="1" colspan="1">47 (0.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">7481 (0.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">47 (0.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">41 (0.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Native Hawaiian or Other Pacific Islander</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">12,099 (0.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">37 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Black or African American</td><td align="center" valign="middle" rowspan="1" colspan="1">2373 (15.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">370,888 (13.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">2373 (15.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">2360 (15.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Asian</td><td align="center" valign="middle" rowspan="1" colspan="1">863 (5.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">111,754 (4.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">863 (5.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">924 (6.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Other Race</td><td align="center" valign="middle" rowspan="1" colspan="1">608 (4.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">116,846 (4.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">608 (4.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">655 (4.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">Social determinants of health associated with adverse outcomes, n (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Housing and economic circumstances</td><td align="center" valign="middle" rowspan="1" colspan="1">584 (3.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">55,768 (2.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">584 (3.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">533 (3.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Employment and unemployment</td><td align="center" valign="middle" rowspan="1" colspan="1">224 (1.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">17,091 (0.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">224 (1.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">183 (1.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Education and literacy</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (0.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">5473 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (0.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">62 (0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Occupational exposure to risk factors</td><td align="center" valign="middle" rowspan="1" colspan="1">23 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">5176 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">23 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Comorbidities, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Alcohol-related disorders</td><td align="center" valign="middle" rowspan="1" colspan="1">1339 (8.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">69,496 (2.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">1339 (8.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1175 (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Nicotine dependence</td><td align="center" valign="middle" rowspan="1" colspan="1">2660 (17.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">209,470 (7.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">2660 (17.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">2530 (16.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">7865 (52.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">799,286 (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">7865 (52.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">8061 (53.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hyperlipidemia</td><td align="center" valign="middle" rowspan="1" colspan="1">6174 (41.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">754,990 (28.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">6174 (41.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">6242 (41.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Diabetes mellitus</td><td align="center" valign="middle" rowspan="1" colspan="1">4407 (29.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">382,180 (14.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37</td><td align="center" valign="middle" rowspan="1" colspan="1">4407 (29.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">4461 (29.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Neoplasms</td><td align="center" valign="middle" rowspan="1" colspan="1">5143 (34.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">546,655 (20.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.31</td><td align="center" valign="middle" rowspan="1" colspan="1">5143 (34.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">5146 (34.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Chronic lower respiratory diseases</td><td align="center" valign="middle" rowspan="1" colspan="1">3776 (25.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">408,114 (15.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">3776 (25.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">3800 (25.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Diseases of liver</td><td align="center" valign="middle" rowspan="1" colspan="1">2390 (15.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">166,690 (6.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.31</td><td align="center" valign="middle" rowspan="1" colspan="1">2390 (15.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">2307 (15.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Chronic kidney disease</td><td align="center" valign="middle" rowspan="1" colspan="1">3358 (22.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">176,135 (6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.46</td><td align="center" valign="middle" rowspan="1" colspan="1">3358 (22.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">3278 (21.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;End-stage renal disease</td><td align="center" valign="middle" rowspan="1" colspan="1">724 (4.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">30,343 (1.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">724 (4.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">641 (4.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Cerebrovascular diseases</td><td align="center" valign="middle" rowspan="1" colspan="1">3010 (20.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">151,654 (5.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44</td><td align="center" valign="middle" rowspan="1" colspan="1">3010 (20.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2917 (19.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Heart failure</td><td align="center" valign="middle" rowspan="1" colspan="1">3015 (20.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">129,363 (4.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">3015 (20.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2820 (18.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Atrial fibrillation and flutter</td><td align="center" valign="middle" rowspan="1" colspan="1">2474 (16.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">129,184 (4.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">2474 (16.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">2417 (16.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8195;Ischemic heart diseases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4093 (27.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">253,795 (9.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4093 (27.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4024 (26.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td></tr></tbody></table><table-wrap-foot><fn><p>Std Diff: standardized difference. A standardized difference (Std diff) of &lt;0.1 indicated an adequate balance between the two groups.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="life-14-00746-t002" orientation="portrait"><object-id pub-id-type="pii">life-14-00746-t002_Table 2</object-id><label>Table 2</label><caption><p>Hazard ratios of the primary and secondary outcomes between the malnutrition group and control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Outcomes</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Patients with Outcome</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Hazard Ratio <break/>(95% CI)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malnutrition Group</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control Group</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Primary outcome</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Post-COVID-19 condition or all-cause hospitalization, or death</td><td align="center" valign="middle" rowspan="1" colspan="1">2683</td><td align="center" valign="middle" rowspan="1" colspan="1">1383</td><td align="center" valign="middle" rowspan="1" colspan="1">2.315 (2.170 to 2.471)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Secondary outcomes</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">All-cause hospitalization</td><td align="center" valign="middle" rowspan="1" colspan="1">2283</td><td align="center" valign="middle" rowspan="1" colspan="1">1257</td><td align="center" valign="middle" rowspan="1" colspan="1">2.151 (2.008 to 2.304)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">All-cause mortality</td><td align="center" valign="middle" rowspan="1" colspan="1">542</td><td align="center" valign="middle" rowspan="1" colspan="1">138</td><td align="center" valign="middle" rowspan="1" colspan="1">4.459 (3.699 to 5.376)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Post-COVID-19 condition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">109</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.707 (1.913 to 3.832)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>CI: confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="life-14-00746-t003" orientation="portrait"><object-id pub-id-type="pii">life-14-00746-t003_Table 3</object-id><label>Table 3</label><caption><p>Subgroup analyses of the primary outcomes between the malnutrition and control groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Subgroup Analyses of Primary Outcome</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Patients with Outcome</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Hazard Ratio (95% CI)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malnutrition Group</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control Group</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">1398</td><td align="center" valign="middle" rowspan="1" colspan="1">727</td><td align="center" valign="middle" rowspan="1" colspan="1">2.306 (2.108 to 2.523)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">1260</td><td align="center" valign="middle" rowspan="1" colspan="1">687</td><td align="center" valign="middle" rowspan="1" colspan="1">2.203 (2.007 to 2.417)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;18&#8211;64 y/o</td><td align="center" valign="middle" rowspan="1" colspan="1">1122</td><td align="center" valign="middle" rowspan="1" colspan="1">459</td><td align="center" valign="middle" rowspan="1" colspan="1">2.848 (2.555 to 3.175)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#8805;65 y/o</td><td align="center" valign="middle" rowspan="1" colspan="1">1649</td><td align="center" valign="middle" rowspan="1" colspan="1">1053</td><td align="center" valign="middle" rowspan="1" colspan="1">1.897 (1.756 to 2.050)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;White</td><td align="center" valign="middle" rowspan="1" colspan="1">2044</td><td align="center" valign="middle" rowspan="1" colspan="1">1039</td><td align="center" valign="middle" rowspan="1" colspan="1">2.337 (2.169 to 2.518)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;American Indian or Alaska Native</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">4.777 (1.032 to 22.113)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0271</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Native Hawaiian or Other Pacific Islander</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.596 (0.568 to 4.489)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3698</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Black or African American</td><td align="center" valign="middle" rowspan="1" colspan="1">485</td><td align="center" valign="middle" rowspan="1" colspan="1">262</td><td align="center" valign="middle" rowspan="1" colspan="1">2.163 (1.860 to 2.514)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Asian</td><td align="center" valign="middle" rowspan="1" colspan="1">108</td><td align="center" valign="middle" rowspan="1" colspan="1">49</td><td align="center" valign="middle" rowspan="1" colspan="1">2.863 (2.042 to 4.013)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Vaccination status</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Unvaccinated</td><td align="center" valign="middle" rowspan="1" colspan="1">2055</td><td align="center" valign="middle" rowspan="1" colspan="1">1088</td><td align="center" valign="middle" rowspan="1" colspan="1">2.261 (2.101 to 2.433)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Receiving &#8805; 2 doses vaccination</td><td align="center" valign="middle" rowspan="1" colspan="1">202</td><td align="center" valign="middle" rowspan="1" colspan="1">109</td><td align="center" valign="middle" rowspan="1" colspan="1">2.085 (1.652 to 2.632)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antiviral agent status</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Receiving antiviral agent</td><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">2.736 (1.669 to 4.486)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8195;Not receiving antiviral agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2920</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1540</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.246 (2.112 to 2.390)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>CI: confidence interval; y/o: years old.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="life-14-00746-t004" orientation="portrait"><object-id pub-id-type="pii">life-14-00746-t004_Table 4</object-id><label>Table 4</label><caption><p>Subgroup analysis of the secondary outcomes between malnutrition and control groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Subgroups</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">All-Cause <break/>Hospitalization</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">All-Cause Mortality</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Post-COVID-19 <break/>Condition</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">2.133 (1.940 to 2.344)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">5.022 (3.828 to 6.587)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.669 (2.164 to 6.219)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">2.013 (1.825 to 2.220)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">5.143 (3.840 to 6.888)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.261 (1.339 to 3.818)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0017</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;18&#8211;64 y/o</td><td align="center" valign="middle" rowspan="1" colspan="1">2.634 (2.351 to 2.950)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">7.397 (4.861 to 11.256)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.949 (2.345 to 6.651)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#8805;65 y/o</td><td align="center" valign="middle" rowspan="1" colspan="1">1.718 (1.583 to 1.866)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.801 (3.100 to 4.660)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.873 (1.160 to 3.025)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0091</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;White</td><td align="center" valign="middle" rowspan="1" colspan="1">2.118 (1.956 to 2.293)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">5.024 (4.045 to 6.241)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.337 (1.646 to 3.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;American Indian or Alaska Native</td><td align="center" valign="middle" rowspan="1" colspan="1">4.255 (0.903,20.038)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0460</td><td align="center" valign="middle" rowspan="1" colspan="1">1.010 (0.063 to 16.144)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9945</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Native Hawaiian or Other Pacific Islander</td><td align="center" valign="middle" rowspan="1" colspan="1">1.246 (0.418 to 3.712)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6920</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Black or African American</td><td align="center" valign="middle" rowspan="1" colspan="1">2.101 (1.796 to 2.458)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.852 (1.843 to 4.413)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.545 (1.078 to 6.624)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0472</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Asian</td><td align="center" valign="middle" rowspan="1" colspan="1">2.762 (1.938 to 3.936)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">7.821 (2.314 to 26.429)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.347 (0.430 to 12.828)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3102</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Vaccination status</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Unvaccinated</td><td align="center" valign="middle" rowspan="1" colspan="1">2.128 (1.969 to 2.301)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.563 (2.913 to 4.358)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.164 (2.113 to 4.736)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Receiving &#8805; 2 doses vaccination</td><td align="center" valign="middle" rowspan="1" colspan="1">1.946 (1.514 to 2.500)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">3.401 (1.939 to 5.963)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.927 (0.712 to 5.210)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1884</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antiviral agent status</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Receiving antiviral agent</td><td align="center" valign="middle" rowspan="1" colspan="1">2.641 (1.588 to 4.393)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">11.964 (1.531 to 93.479)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0025</td><td align="center" valign="middle" rowspan="1" colspan="1">1.134 (0.071 to 18.132)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9290</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8195;Not receiving antiviral agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.068 (1.937 to 2.208)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.158 (3.492 to 4.952)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.234 (2.296 to 4.556)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>CI: confidence interval, HR: hazard ratio, y/o: years.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>